Par Drugs & Chemicals Other Announcement
The company submitted the routine Regulation 74(5) compliance certificate from its RTA regarding share dematerialization for the quarter ended September 30, 2026.
ALFA Filings
Every announcement, straight from the exchange
Every Par Drugs & Chemicals other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
The company submitted the routine Regulation 74(5) compliance certificate from its RTA regarding share dematerialization for the quarter ended September 30, 2026.
Par Drugs and Chemicals Limited is notifying shareholders about access to the FY 2025-26 Annual Report and 27th AGM notice via web-link.
Par Drugs and Chemicals Limited submitted its quarterly compliance certificate under SEBI Regulations for the period ended March 31, 2026. The registrar, MUFG Intime India, confirmed that share certificates received for dematerialisation were processed and cancelled within prescribed timelines. This is a routine administrative filing with no material financial impact.